MINNEAPOLIS, Nov. 8, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today
announced that it will present at the following investor
conferences:
UBS Global Healthcare Conference
November 12, 2024
9:30 AM PST
Stifel 2024 Healthcare Conference
November 19, 2024
8:00 AM EST
Stephens NASH 2024 Conference
November 20, 2024
11:00 AM CST
A live webcast of the presentations can be accessed via the IR
Calendar page of Bio-Techne's Investor Relations website at
https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH)
is a global life sciences company providing innovative tools and
bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With hundreds of
thousands of products in its portfolio, Bio-Techne generated
approximately $1.2 billion in net
sales in fiscal 2024 and has approximately 3,100 employees
worldwide. For more information on Bio-Techne and its brands,
please visit https://www.bio-techne.com or follow the
Company on social media
at: Facebook, LinkedIn, Twitter or YouTube.
|
|
|
Contact:
|
David Clair, Vice
President, Investor Relations & Corporate
Development
|
|
david.clair@bio-techne.com
|
|
612-656-4416
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302298610.html
SOURCE Bio-Techne Corporation